COP Options Skew Turns Bearish as Shorts Build Into November Print

ConocoPhillips fell 2.3% on Tuesday to $147.96. The put-call ratio hit 0.78, sitting 2.8 standard deviations above its 20-day mean of 0.74. That is the most defensive options positioning COP has seen in weeks, with earnings eight days away on November 5.

Why this matters

Three separate datasets moved in the same direction on the same day. Options traders bought protection at an elevated pace. Short interest climbed 20% over the past week to 1.51% of float. And retail attention, measured by Wikipedia views and ORTEX stock page traffic, hit a z-score of 3.0 against its own 90-day average. The stock has already gained 16.2% over the past month, so the question the data raises is whether positioning is catching up to a price that has run ahead of the fundamental story.

Options Traders Load Up on Puts

The PCR of 0.78 compares with a 20-day mean of 0.74 and a 52-week low of 0.66. It is not at a 52-week extreme, the 52-week high is 1.00, but the two-standard-deviation-plus move in a single session is the sharpest single-day shift in the recent record. Prior earnings prints have moved COP about 2.2% on the day and 8.2% over the following week, based on the August 2026 report. Options traders appear to be pricing in a wider range of outcomes this time.

Piper Sandler assumed coverage on October 27 with a Neutral rating and a $157 price target, the latest in a string of recent analyst moves. Susquehanna lifted its target to $175 earlier in the week. Morgan Stanley holds Overweight with a $159 target. The consensus mean stands at $151.48, close to current levels. As the previous ORTEX note observed, the gap between price and consensus has compressed materially since COP's rally through October. Piper's entry at a sub-$160 Neutral is the clearest signal that some on the Street see limited upside from here.

Shorts Rebuild After September Retreat

Short interest fell sharply through September from around 18.8 million shares to a trough near 14.6 million. It has since recovered to 18.7 million shares, roughly 1.51% of free float. That is a low absolute level for a large-cap E&P, and the borrow market confirms there is no shortage of available stock: availability remains at the maximum reading in the data, with 796 million shares available. Cost to borrow is 0.29%, down 25% on the week. This is not a squeeze setup. The short rebuild looks more like hedging ahead of a print than a conviction directional bet.

The ORTEX short score stands at 31.3, little changed from 30.1 ten days ago. Among peers, CVX fell 1.6% on the day, XOM fell 2.5%, and OXY dropped 2.1%. COP's 1.4% gain over the past week is in line with the peer median of 1.2%, so the options skew appears to be stock-specific rather than sector-wide.

Retail Attention Spike

Wikipedia views and ORTEX stock page traffic hit a combined z-score of 3.0 against COP's own 90-day history as of October 28. The dataset carries no measured lead to financial results. It reflects attention, not a revenue signal. But a retail attention spike of this size, arriving alongside elevated put buying and a short rebuild in the week before results, is worth noting as a sign the November 5 print is drawing a broader audience than usual.

What to Watch

The specific date is November 5. That is when ConocoPhillips reports, and when the options positioning, short interest level, and analyst target distribution will be tested against actual numbers. The price that matters for the analyst debate is $151.48, the consensus mean target. COP closed at $147.96 on Tuesday.